Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience

BACKGROUND: Pheochromocytoma (PHEO) and paraganglioma (PGL) are rare neuroendocrine tumors releasing catecholamines. Metastatic pheochromocytomas/paragangliomas (PPGLs) occur in about 5–26% of cases. To date, the management of patients affected by metastatic disease is a challenge in the absence of...

Descripción completa

Detalles Bibliográficos
Autores principales: De Filpo, G., Cantini, G., Rastrelli, G., Vannini, G., Ercolino, T., Luconi, M., Mannelli, M., Maggi, M., Canu, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741659/
https://www.ncbi.nlm.nih.gov/pubmed/34227051
http://dx.doi.org/10.1007/s40618-021-01629-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741659/
https://www.ncbi.nlm.nih.gov/pubmed/34227051
http://dx.doi.org/10.1007/s40618-021-01629-x

Ejemplares similares